| |
|
|
|
|
| Slide Lecture Programs |
| 2006 Core Curriculum |
| Antiplatelet Interventions in ACS |
March 10, 2006
|
| V: |
Clinical Insights, Risk Stratification, and Enhancing Outcomes
- The CRUSADE data demonstrated a dose-response relationship between the degree of excess dose and bleeding for UFH, LMWH, and GP IIb/IIIa inhibitors.
- After adjustment, patients receiving a mild excess of UFH had similar rates of bleeding as those receiving a recommended dose, but those receiving a major excess had a 31% increased risk.
- Any degree of excess GP IIb/IIIa inhibitor significantly increased bleeding risk.
|
|
|
Resources